Analogue vs Human Insulin for Youth with Type 1 Diabetes
‘Analogue vs Human Insulin for Youth with Type 1 Diabetes in Low-Resource Settings: A Randomized Controlled Trial (AnHuT1D Trial):’
In collaboration with esteemed partners like the University of Pittsburgh School of Medicine and the London School of Hygiene, we are conducting the AnHuT1D Trial. This randomized controlled trial focuses on comparing analogue insulin to human insulin for youth with type 1 diabetes in low-resource settings. By evaluating the efficacy and impact of different insulin types, we aim to optimize treatment strategies tailored to the unique needs of our patients.